Per IEC 60601-1, essential performance is the performance of a clinical function, other than that related to basic safety, where loss or degradation beyond limits specified by the manufacturer results in an unacceptable risk. Manufacturers identify essential performance through risk analysis and record it in the risk management file, and test labs then check that it is maintained during and after tests such as EMC immunity and single fault conditions. Examples include accurate dose delivery for an infusion pump or alarm generation for a patient monitor. Particular standards in the IEC 60601-2 series often define essential performance for specific device types.

Why it matters

Defining essential performance correctly is foundational for risk analysis, testing, and labeling under the 60601 family of standards.

Common pitfalls

•Failing to distinguish between basic safety and essential performance can lead to an incomplete risk assessment.
•Not clearly defining the limits for loss or degradation of essential performance can result in subjective and inconsistent evaluations.
•Assuming all functions of a device contribute to essential performance can overcomplicate testing and validation efforts.
•Ignoring the impact of reasonably foreseeable misuse on essential performance can leave critical risks unaddressed.

Sources

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.